Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 ILa | -0.99% | +11.11% | +185.71% |
04-30 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-29 | Top Premarket Gainers | MT |
1st Jan change | Capi. | |
---|---|---|
+185.71% | 14.99M | |
+33.33% | 49.46B | |
+1.76% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-22.67% | 18.64B | |
+8.22% | 13.16B | |
+29.58% | 12.55B | |
+24.25% | 12.1B |
- Stock Market
- Equities
- XTLB Stock
- News XTL Biopharmaceuticals Ltd.
- XTL Biopharmaceuticals Ltd. Announces Resignation David Kestenbaum as Chief Financial Officer